Ashland Inc. (ASH)
Market Cap | 3.59B |
Revenue (ttm) | 2.11B |
Net Income (ttm) | 169.00M |
Shares Out | 47.11M |
EPS (ttm) | 3.35 |
PE Ratio | 22.75 |
Forward PE | 16.72 |
Dividend | $1.62 (2.13%) |
Ex-Dividend Date | Aug 30, 2024 |
Volume | 331,571 |
Open | 75.89 |
Previous Close | 76.39 |
Day's Range | 75.04 - 76.25 |
52-Week Range | 75.04 - 102.50 |
Beta | 0.88 |
Analysts | Buy |
Price Target | 102.50 (+34.5%) |
Earnings Date | Nov 6, 2024 |
About ASH
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight m... [Read more]
Financial Performance
In 2024, Ashland's revenue was $2.11 billion, a decrease of -3.56% compared to the previous year's $2.19 billion. Earnings were $169.00 million, a decrease of -5.06%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for ASH stock is "Buy." The 12-month stock price forecast is $102.5, which is an increase of 34.50% from the latest price.
News
Ashland board authorizes quarterly dividend
WILMINGTON, Del., Nov. 14, 2024 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock. T...
Ashland Inc. (ASH) Q4 2024 Earnings Call Transcript
Ashland Inc. (NYSE:ASH) Q4 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants William Whitaker - VP, Finance and Director, IR Guillermo Novo - Chair and CEO Kevin Willis -...
Top 3 Materials Stocks That Are Preparing To Pump In Q4
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
Ashland to host live 2024 strategy update event for analysts and investors
WILMINGTON, Del., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a strategy update event for analysts and investors on Tuesday, December 10, 2024, in New York City. The company w...
Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast
WILMINGTON, Del., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2024 earnings release at approximately 5 p.m. ET on Wednesday, Nov...
D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire's Acquisition of Pharmachem
NEW YORK--(BUSINESS WIRE)--D.A. Davidson & Co. announced today that it served as exclusive financial advisor to Turnspire Capital Partners LLC (“Turnspire”) on an asset-backed credit facility to finan...
Ashland completes sale of nutraceuticals business
WILMINGTON, Del., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced it has completed the sale of its nutraceuticals business to an affiliate of Turnspire Capital Partners LLC...
Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions
KEARNY, N.J.--(BUSINESS WIRE)--Pharmachem Innovations, LLC (“Pharmachem” or the “Company”), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent co...
Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland
NEW YORK--(BUSINESS WIRE)--Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC (“Pharmachem” or the “Company”), ...
Ashland Inc. (ASH) Q3 2024 Earnings Call Transcript
Ashland Inc. (NYSE:ASH) Q3 2024 Earnings Conference Call August 7, 2024 10:00 AM ET Company Participants William Whitaker - Vice President-Finance and Director-Investor Relations Guillermo Novo - Cha...
Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024
WILMINGTON, Del., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the third quarter of fiscal year 2024, which ended June 30, 2024, and issued its out...
Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast
WILMINGTON, Del., July 17, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter earnings release at approximately 5 p.m. ET on Tuesday, August 6, 2024. Th...
Ashland achieves certification by Fair Wage Network
WILMINGTON, Del., June 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has strengthened its performance towards environmental, social and governance (ESG) practices and a more just and equitable...
Ashland Board appoints Ashish K. Kulkarni as new director
WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup com...
Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business
NEW YORK--(BUSINESS WIRE)--Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has signed a definitive agreement to acquire the nutraceuticals business of Ashland Inc. (NYSE...
Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
WILMINGTON, Del., May 07, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners ...
Ashland Inc. (ASH) Q2 2024 Earnings Call Transcript
Ashland Inc. (NYSE:ASH) Q2 2024 Results Conference Call May 1, 2024 9:00 AM ET Company Participants William Whitaker - Vice President of Finance and Director of Investor Relations Guillermo Novo - Ch...
Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024
WILMINGTON, Del., April 30, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the second quarter of fiscal year 2024, which ended March 31, 2024, and issued its ...
Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast
WILMINGTON, Del., April 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter earnings release at approximately 5 p.m. ET on Tuesday, April 30, 2024. ...
Ashland Board appoints Scott A. Tozier as new director
Tozier is strategic advisor to the CEO, and former executive vice president and chief financial officer of Albemarle Corporation Tozier is strategic advisor to the CEO, and former executive vice presi...
Ashland announces executive organization changes to personal care and specialty additives
WILMINGTON, Del. , April 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), the global additives and specialty ingredients company today announced executive organization changes to its personal ca...
Ashland Inc. (ASH) Q1 2024 Earnings Call Transcript
Ashland Inc. (ASH) Q1 2024 Earnings Call Transcript
Ashland reports financial results1 for first quarter fiscal 2024; issues outlook for second quarter and full-year fiscal 2024
Sales of $473 million, down 10 percent from the prior-year quarter Net income (including discontinued operations) of $26 million, or $0.51 per diluted share Income from continuing operations of $28 mi...
Ashland sets date for fiscal 2024 first-quarter earnings release and conference call webcast
WILMINGTON, Del., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its first-quarter earnings release at approximately 5 p.m. ET on Tuesday, January 30, 2024. ...